Organogenesis Holdings (ORGO) Non-Current Debt (2017 - 2024)
Historic Non-Current Debt for Organogenesis Holdings (ORGO) over the last 8 years, with Q3 2024 value amounting to $56.2 million.
- Organogenesis Holdings' Non-Current Debt fell 960.12% to $56.2 million in Q3 2024 from the same period last year, while for Sep 2024 it was $56.2 million, marking a year-over-year decrease of 960.12%. This contributed to the annual value of $60.7 million for FY2023, which is 828.31% down from last year.
- Latest data reveals that Organogenesis Holdings reported Non-Current Debt of $56.2 million as of Q3 2024, which was down 960.12% from $57.7 million recorded in Q2 2024.
- Organogenesis Holdings' 5-year Non-Current Debt high stood at $74.5 million for Q3 2021, and its period low was $37.3 million during Q2 2021.
- Moreover, its 5-year median value for Non-Current Debt was $60.7 million (2023), whereas its average is $60.3 million.
- Per our database at Business Quant, Organogenesis Holdings' Non-Current Debt crashed by 2958.04% in 2021 and then surged by 8495.31% in 2022.
- Quarter analysis of 5 years shows Organogenesis Holdings' Non-Current Debt stood at $60.0 million in 2020, then grew by 17.95% to $70.8 million in 2021, then dropped by 6.41% to $66.2 million in 2022, then fell by 8.28% to $60.7 million in 2023, then dropped by 7.56% to $56.2 million in 2024.
- Its Non-Current Debt stands at $56.2 million for Q3 2024, versus $57.7 million for Q2 2024 and $59.4 million for Q1 2024.